Menu
GeneBe

19-48756967-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_019113.4(FGF21):c.277A>G(p.Ile93Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

FGF21
NM_019113.4 missense

Scores

8
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.42
Variant links:
Genes affected
FGF21 (HGNC:3678): (fibroblast growth factor 21) Theis gene encodes a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes. This protein is a secreted endocrine factor that functions as a major metabolic regulator. The encoded protein stimulates the uptake of glucose in adipose tissue. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.32767966).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FGF21NM_019113.4 linkuse as main transcriptc.277A>G p.Ile93Val missense_variant 3/4 ENST00000593756.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FGF21ENST00000593756.6 linkuse as main transcriptc.277A>G p.Ile93Val missense_variant 3/41 NM_019113.4 P1
FGF21ENST00000222157.5 linkuse as main transcriptc.277A>G p.Ile93Val missense_variant 2/31 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461832
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 17, 2022The c.277A>G (p.I93V) alteration is located in exon 2 (coding exon 2) of the FGF21 gene. This alteration results from a A to G substitution at nucleotide position 277, causing the isoleucine (I) at amino acid position 93 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Uncertain
0.045
T
BayesDel_noAF
Benign
-0.17
Cadd
Benign
19
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.70
D;D
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.061
FATHMM_MKL
Uncertain
0.81
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.33
T;T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Uncertain
2.6
M;M
MutationTaster
Benign
0.69
N
PrimateAI
Uncertain
0.57
T
Sift4G
Benign
0.20
T;T
Polyphen
0.014
B;B
Vest4
0.38
MutPred
0.65
Gain of MoRF binding (P = 0.1749);Gain of MoRF binding (P = 0.1749);
MVP
0.94
MPC
0.035
ClinPred
0.30
T
GERP RS
3.1
Varity_R
0.084
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-49260224; API